“Whereas the spread of Human ImmunodeficiencyVirus and Acquired Immune DeficiencySyndrome is a matter of grave concern to all and there is an urgent need for the prevention and control of said virus and syndrome”
“Notwithstanding anything contained in any law for the time being in force, a parent or legal guardian of a child affected by HIV and AIDS may appoint, by making a will, an adult person who is a relative or friend, or a person below the age of eighteen years who is the managing member of the family affected by HIV and AIDS, as referred to in section 33, to act as legal guardian immediately upon incapacity or death of such parent or legal guardian, as the case may be.”
“ANTI-RETROVIRAL THERAPY AND OPPORTUNISTIC INFECTION MANAGEMENT FOR PEOPLE LIVING WITH HIVCHAPTER VIANTI-RETROVIRAL THERAPY AND OPPORTUNISTIC INFECTION MANAGEMENT FOR PEOPLE LIVING WITH HIV Central Government and State Government to take measures. 13. The Central Government and every State Government, as the case may be, shall take all such measures as it deems necessary and expedient for the prevention of spread of HIV or AIDS, in accordance with the guidelines.”
“And then, importantly, there are immunocompromised individuals — those who have immunosuppressive medical conditions, either primary immunodeficiencies or acquired immune deficiencies, such as HIV — or individuals who are receiving immunosuppressive treatment or chemotherapy. That could be either due to an underlying neoplasm or, maybe even more frequently, to individuals with one form or another of an autoimmune disease requiring suppression of a hyperactive immune system. It’s estimated that about 3 percent of U.S. adults fall within that category.”
“The Central Government and the State Government shall formulate HIV and AIDS related information, education and communication programmes which are age-appropriate, gender-sensitive, non-stigmatising and non-discriminatory.”
“Nearly 75,000 Americans have been diagnosed as having the fatal disease AIDS, and more than 41,000 have already died from it. The Public HealthService estimates that an additional one to one-and-a-half million Americans have been infected by the Human Immunodeficiency Virus (HIV) , which causes AIDS. Most of the infected individuals now show no symptoms, but it is likely that over the next few years they will develop AIDS or AIDS-related illnesses.”
“In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro. J Infect Dis 178: 1024–1029. Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, et al. (2007) Evolutionary and biomedical insights from the rhesusmacaque genome. Science 316: 222–234. Deeks SG, Walker BD (2007) Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.”
“Much of the experimental research has been directed towards the question of acquiredimmunity and many interesting facts have been discovered. Flexner and Lewis, Landsteiner and Levaditi, and Römer and Joseph demonstrated that monkeys which recovered from one infection with the virus of poliomyelitis are immune. According to Joseph and Römer this immunity is present even when the first infection produces no clinical symptoms. Moreover, antibodies can be demonstrated in the blood of such immune monkeys.”
“HIV infection does fall well within the general definition set forth by the regulations, however.The disease follows a predictable and, as of today, an unalterable course. Once a person is infected with HIV, the [p. 634] virus invades different cells in the blood and in body tissues. Certain white blood cells, known as helper T-lymphocytes or CD4+ cells, are particularly vulnerable to HIV. The virus attaches to the CD4 receptor site of the target cell and fuses its membrane to the cell's membrane.”
“As noted earlier, infection with HIV causes immediate abnormalities in a person's blood, and the infected person's white cell count continues to drop throughout the course of the disease, even when the attack is concentrated in the lymphnodes. In light of these facts, HIV infection must be regarded as a physiological disorder with a constant and detrimental effect on the infected person's hemic and lymphatic systems from the moment of infection. HIV infection satisfies the statutory and regulatory definition of a physical impairment during every stage of the disease.”
“Ten thousand children in the United States today are living with the human immunodeficiency virus (HIV) . Ten million children worldwide will become infected with HIV before the millennium. Over 5,000 cases of pediatric AIDS and 1,500 cases of AIDS in adolescents ages 13 through 19 have been reported in this country alone. The tragedy is magnified for our youth, as the epidemic reaches far beyond those actually infected-it will leave up to 125,000 children and teenagers orphaned in this country by the end of this decade.”
“Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simianimmunodeficiency virus. J Biol Chem 275: 18946–18961. Thomas SM, Tse DB, Ketner DS, Rochford G, Meyer DA, et al. (2006) CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men.”
“The migration reduces the viral presence in other parts of the body, with a corresponding diminution in physical manifestations of the disease. The virus, however, thrives in the lymph nodes, which, as a vital point of the body's immune response system, represents an ideal environment for the infection of other CD4‘ cells.”
“HIV destroys the immune system and attacks the central nervous system, leading to devastating physical consequences and then to death. Because the virus has a long incubationperiod and the progress of the disease varies sharply from individual to individual, people can unwittingly carry and spread it for years.”
“In general, the innate and acquiredimmune responses are not activated independently. Their optimal performance is when they complement each other. In particular, the AIS’ antibodies are able to direct the IIS’ components toward the relevant objects.”
“HIV/AIDS and VL are locked in a vicious circle of mutual reinforcement. VL accelerates the onset of AIDS by infecting macrophages throughout the reticuloendothelial system, rendering the body more susceptible by stimulating replication of the virus.”
“Point number two is that the immunity to the infection is not solely determined by the percent of people who have antibodies. If you look at the research — and there's been about 24 papers at least on the immunity from T-cells — that's a different type of immunity than antibodies. And without being boring, the reality is that — according to the papers from Sweden, Singapore, and elsewhere — there is cross-immunity, highly likely from other infections, and there is also T-cell immunity. And the combination of those makes the antibodies a small fraction of the people that have immunity.”
“The preceding findings underscored that over and above the AIDS risk conveyed by the CD4 cell count and viral load, CCL3L1-CCR5 GRG status may serve as a unique parameter to identify HIV-infected individuals who are at an increased risk of developing AIDS. To investigate further this possibility, we considered whether GRGs and laboratory markers can be combined in a clinically meaningful way to enhance AIDS prognostication.”
“Rougeau, N & Cohen, EA (1999) , “Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection”, J Virol 73: 4101–4109, 10196306, pmid:10196306 ↑ Hogan, TH”
“The virus concentrates in the blood. The assault on the immune system is immediate. The victim suffers from a sudden and serious decline in the number of white blood cells. There is no latency period. Mononucleosis-like symptoms often emerge between six days and six weeks after infection, at times accompanied by fever, headache, enlargement of the lymph nodes (lymphadenopathy) , muscle pain (myalgia) , rash, lethargy, gastrointestinal disorders, and neurological disorders.”
“The results of this study conducted in a large, and well-characterized natural history cohort of HIV-infected individuals indicate that in addition to the traditional markers of vulnerability (baseline CD4+ T cell count, viral load and rate of CD4+ T cell decline) , the inclusion of a measure of genetic risk might offer an adjunctive, and complementary risk-stratification tool that may provide an improved method for identifying persons at high risk for future AIDS related events.”
“Today, as a direct outcome of their basic research, gene therapy has been devised for children with severe combined immune deficiency; accurate diagnostic tests are available for many life-threatening diseases and conditions”
“In some cases, clear induction of antibodies with activity in impairing parasite growth in a standardized growth inhibitory assay has been achieved [47] but that has not been associated with significant vaccine efficacy. A telling comparator may be that strong adjuvants have generally induced antibody levels comparable to those seen in semi-immune adults living in endemic areas. Such adults have significant protective immunity from natural exposure because they have antibody responses to very large numbers of antigens not just one or two as in vaccinees.”
“The immune system produces antibodies as a defense to foreign agents called antigens. When a particular antigen—a virus, for example—enters the body, the immune system generates antibodies to attack it. In a successful attack, the antibodies target and bind to the antigen, stopping it from causing harm to the body.”
“CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group. Aids 12: 1823–1832. (2000) Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group. AIDS Res Hum Retroviruses 16: 1123–1133. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene.”
“There are some diseases in which there is little reason for thinking that any immunity is acquired, as in the case of tuberculosis, while there are others in which the immunity is very great and very lasting, as in the case of scarletfever. Moreover, the immunity differs with individuals. While some persons appear to acquire a lasting immunity by recovery from a single attack, others will yield to a second attack very readily.”
“Immunity may be acquired in several ways. It is commonly known that one attack of certain communicable diseases renders the individual immune for a varying length of time, and sometimes for life. Among these diseases are smallpox, measles, whooping-cough, scarlet fever, infantile paralysis, typhoid fever, chicken-pox, and mumps; erysipelas and pneumonia on the other hand appear to diminish resistance and to leave a person more susceptible to later attacks.”
“When you think in terms of having an immunosuppressed state — for example, if you’re on glucocorticoids for rheumatoid arthritis or you’re on some of the monoclonal antibodies that block the markers of inflammation — that under those circumstances, if that’s where you are, there is not a safety issue with regard to the vaccine.”
“These findings also have value for improving our understanding of the factors that influence HIV-AIDS pathogenesis and for the interpretation of genotype-phenotype association studies in general. The ability of the GRGs to provide an additive measure of AIDS risk, including in those with high CD4 cell counts, suggests that the impact of these host factors during chronic infection is partly through viral load-independent mechanisms that are likely operative in the proximal end of the causal pathways that affect CD4 cell loss and establishment of the steady-state viral load.”
“HIV-1-infected subjects are typically started on highly active antiretroviral therapy (HAART) when their CD4+ T cell count reaches a threshold below which their risk for developing AIDS increases significantly [6] , [7] , [8] , [9] . These HAART-initiating CD4+ T cell count thresholds vary depending on the clinical and economic settings, but are typically between 200 and 350 CD4+ T cells/mm3 [6] , [7] , [8] , [9] .”
“Belardelli, F; et al. (1998) , “The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS”, J Exp Med 187: 403–413, 944972010.1084/jem.187.3.403, pmid:9449720, DOI 10.1084/jem.187.3.403 ↑ Stewart, SA; Poon, B; Jowett, JB & Chen, IS (1997) , “Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cyclearrest”, J Virol 71: 5579–5592, 9188632, pmid:9188632 1 2 Muthumani, K”
“Systemic lupus erythematosus or lupus is often called "the great impersonator" because it can mimic so many other diseases. A disorder of the body's immune system, lupus may affect the joints, the skin, and one or more internal organs (such as the kidneys, heart, and brain) in varying combinations. As many as 500,000 Americans-mostly women in their childbearing years-may suffer from this autoimmune disorder.”
“A person is regarded as having AIDS when his or her CD4+ count drops below 200 cells/mm3 of blood or when CD4+ cells comprise less than 14% of his or her total lymphocytes. U. S. Dept. of Health and Human Services, Public Health Service, CDC, 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults, 41 Morbidity and Mortality Weekly Rep., No.”
“Serum samples may be tested for precipitating antibodies to the FMD VIAA, for neutralizing antibodies to FMDVs, SVDV, VESVs, and VSVs, and for CF antibodies to VSVs, with results available in 1-3 days. Virus-neutralizing antibodies are serotype-specific for FMDV, and animals infected for the first time characteristically develop the highest titer against the homologous subtype. Antibodies to FMD VIAA were used historically to differentiate the immune response to active infection from that of vaccination.”